1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ACT-462206: new trials by email Literature Review of ACT-462206 trials Research Report on ACT-462206
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206 ACT-462206 5 mg, ACT-462206 25 mg, ACT-462206 100mg - Safety, Tolerability | Phase 1 | Completed | Idorsia Pharmaceuticals Ltd. | 56 | 2011-11-01 | 2018-07-10 |
Idorsia Pharmaceuticals Ltd. (1)
Netherlands (1)